Plante Moran Financial Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-105
| Closed | -$10K | – | 1057 |
|
|
2021
Q4 | $10K | Hold |
105
| – | – | ﹤0.01% | 693 |
|
|
2021
Q3 | $6K | Hold |
105
| – | – | ﹤0.01% | 773 |
|
|
2021
Q2 | $7K | Hold |
105
| – | – | ﹤0.01% | 744 |
|
|
2021
Q1 | $7K | Hold |
105
| – | – | ﹤0.01% | 730 |
|
|
2020
Q4 | $8K | Hold |
105
| – | – | ﹤0.01% | 660 |
|
|
2020
Q3 | $8K | Hold |
105
| – | – | ﹤0.01% | 645 |
|
|
2020
Q2 | $7K | Hold |
105
| – | – | ﹤0.01% | 564 |
|
|
2020
Q1 | $4K | Hold |
105
| – | – | ﹤0.01% | 610 |
|
|
2019
Q4 | $5K | Hold |
105
| – | – | ﹤0.01% | 628 |
|
|
2019
Q3 | $5K | Hold |
105
| – | – | ﹤0.01% | 699 |
|
|
2019
Q2 | $6K | Hold |
105
| – | – | ﹤0.01% | 637 |
|
|
2019
Q1 | $5K | Hold |
105
| – | – | ﹤0.01% | 648 |
|
|
2018
Q4 | $4K | Sell |
105
-112
| -52% | -$4.4K | ﹤0.01% | 639 |
|
|
2018
Q3 | $10K | Sell |
217
-28
| -11% | -$1.14K | ﹤0.01% | 501 |
|
|
2018
Q2 | $11K | Sell |
245
-60
| -20% | -$2.58K | 0.01% | 541 |
|
|
2018
Q1 | $12K | Sell |
305
-100
| -25% | -$3.89K | 0.01% | 584 |
|
|
2017
Q4 | $14K | Buy |
405
+85
| +27% | +$2.42K | 0.01% | 552 |
|
|
2017
Q3 | $8K | Hold |
320
| – | – | ﹤0.01% | 589 |
|
|
2017
Q2 | $5K | Sell |
320
-174
| -35% | -$2.39K | ﹤0.01% | 680 |
|
|
2017
Q1 | $7K | Buy |
494
+320
| +184% | +$4.74K | ﹤0.01% | 662 |
|
|
2016
Q4 | $2K | Hold |
174
| – | – | ﹤0.01% | 887 |
|
|
2016
Q3 | $3K | Hold |
174
| – | – | ﹤0.01% | 811 |
|
|
2016
Q2 | $3K | Hold |
174
| – | – | ﹤0.01% | 760 |
|
|
2016
Q1 | $3K | Hold |
174
| – | – | ﹤0.01% | 683 |
|
|
2015
Q4 | $3K | Hold |
174
| – | – | ﹤0.01% | 833 |
|
|
2015
Q3 | $3K | Hold |
174
| – | – | ﹤0.01% | 647 |
|
|
2015
Q2 | $8K | Hold |
174
| – | – | 0.01% | 561 |
|
|
2015
Q1 | $8K | Hold |
174
| – | – | 0.01% | 552 |
|
|
2014
Q4 | $6K | Hold |
174
| – | – | ﹤0.01% | 639 |
|
|
2014
Q3 | $7K | Hold |
174
| – | – | 0.01% | 631 |
|
|
2014
Q2 | $10K | Hold |
174
| – | – | 0.01% | 549 |
|
|
2014
Q1 | $11K | Hold |
174
| – | – | 0.01% | 356 |
|
|
2013
Q4 | $10K | Hold |
174
| – | – | 0.01% | 459 |
|
|
2013
Q3 | $9K | Hold |
174
| – | – | 0.01% | 409 |
|
|
2013
Q2 | $13K | Buy |
+174
| New | +$14.2K | 0.01% | 309 |
|
Plante Moran Financial Advisors's ARNA Position: Q1 2022 in Review
Plante Moran Financial Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 105 shares — an estimated $10K sold.
Plante Moran Financial Advisors first reported a position in ARNA in Q2 2013 and held it in 35 quarters. The position peaked at $14K in Q4 2017. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Plante Moran Financial Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Plante Moran Financial Advisors sold 105 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $10K.
- Plante Moran Financial Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
- Plante Moran Financial Advisors's Arena Pharmaceuticals Inc position peaked at $14K in Q4 2017.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Plante Moran Financial Advisors's 13F filing for Q1 2022, filed 6 May 2022.